Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Jun;15(6):677–682. doi: 10.1111/j.1365-2125.1983.tb01549.x

Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects.

P J Barnes, N B Pride
PMCID: PMC1427940  PMID: 6135437

Abstract

We have compared bronchodilator dose-response curves to inhaled salbutamol in seven normal and eight asthmatic subjects. In all normal subjects maximal bronchodilatation measured by partial flow volume curves was achieved at a cumulative dose of 110 micrograms. The dose necessary to produce half maximal response (ED50) was 23 +/- 2 micrograms (mean +/- s.e. mean) with a range of 18-28 micrograms. In asthmatic subjects maximal bronchodilatation measured by FEV1 and by maximal flow volume curves was achieved at significantly higher (P less than 0.01) doses of salbutamol with a mean ED50 of 83 +/- 28 micrograms and range of 25-251 micrograms. There was a significant (P less than 0.05) correlation between ED50 and % predicted baseline FEV1. This is more likely to reflect impaired access of drug for airway beta-adrenoceptors than impaired beta-adrenoceptor function in asthma. In five asthmatic subjects dose-response curves to salbutamol and isoprenaline were compared and found to be similar, thus providing no evidence that salbutamol is a partial agonist in vivo, as it appears to be in vitro.

Full text

PDF
677

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J., Gribbin H. R., Osmanliev D., Pride N. B. Partial flow-volume curves to measure bronchodilator dos-response curves in normal humans. J Appl Physiol Respir Environ Exerc Physiol. 1981 Jun;50(6):1193–1197. doi: 10.1152/jappl.1981.50.6.1193. [DOI] [PubMed] [Google Scholar]
  2. Brooks S. M., McGowan K., Bernstein I. L., Altenau P., Peagler J. Relationship between numbers of beta adrenergic receptors in lymphocytes and disease severity in asthma. J Allergy Clin Immunol. 1979 Jun;63(6):401–406. doi: 10.1016/0091-6749(79)90213-6. [DOI] [PubMed] [Google Scholar]
  3. Conolly M. E., Greenacre J. K. The beta-adrenoceptor of the human lymphocyte and human lung parenchyma. Br J Pharmacol. 1977 Jan;59(1):17–23. doi: 10.1111/j.1476-5381.1977.tb06971.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Conolly M. E., Greenacre J. K. The lymphocyte beta-adrenoceptor in normal subjects and patients with bronchial asthma: the effect of different forms of treatment on receptor function. J Clin Invest. 1976 Dec;58(6):1307–1316. doi: 10.1172/JCI108586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davies D. S. Pharmacokinetics of inhaled substances. Postgrad Med J. 1975;51(7 Suppl):69–75. [PubMed] [Google Scholar]
  6. Davis C., Conolly M. E., Greenacre J. K. Beta-adrenoceptors in human lung, bronchus and lymphocytes. Br J Clin Pharmacol. 1980 Nov;10(5):425–432. doi: 10.1111/j.1365-2125.1980.tb01783.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dolovich M. B., Sanchis J., Rossman C., Newhouse M. T. Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Appl Physiol. 1976 Mar;40(3):468–471. doi: 10.1152/jappl.1976.40.3.468. [DOI] [PubMed] [Google Scholar]
  8. Galant S. P., Duriseti L., Underwood S., Allred S., Insel P. A. Beta adrenergic receptors of polymorphonuclear particulates in bronchial asthma. J Clin Invest. 1980 Mar;65(3):577–585. doi: 10.1172/JCI109702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harvey J. E., Baldwin C. J., Wood P. J., Alberti K. G., Tattersfield A. E. Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) 1981 May;60(5):579–585. doi: 10.1042/cs0600579. [DOI] [PubMed] [Google Scholar]
  10. Holgate S. T., Baldwin C. J., Tattersfield A. E. beta-adrenergic agonist resistance in normal human airways. Lancet. 1977 Aug 20;2(8034):375–377. doi: 10.1016/s0140-6736(77)90304-x. [DOI] [PubMed] [Google Scholar]
  11. Holgate S. T., Stubbs W. A., Wood P. J., McCaughey E. S., Alberti K. G., Tattersfield A. E. Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci (Lond) 1980 Sep;59(3):155–161. doi: 10.1042/cs0590155. [DOI] [PubMed] [Google Scholar]
  12. Jenne J. W., Chick T. W., Strickland R. D., Wall F. J. Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation. J Allergy Clin Immunol. 1977 May;59(5):383–390. doi: 10.1016/0091-6749(77)90023-9. [DOI] [PubMed] [Google Scholar]
  13. Kariman K. Beta-adrenergic receptor binding in lymphocytes from patients with asthma. Lung. 1980;158(1):41–51. doi: 10.1007/BF02713701. [DOI] [PubMed] [Google Scholar]
  14. Minneman K. P., Hegstrand L. R., Molinoff P. B. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979 Jul;16(1):34–46. [PubMed] [Google Scholar]
  15. Morris H. G., Rusnak S. A., Barzens K. Leukocyte cyclic adenosine monophosphate in asthmatic children. Effects of adrenergic therapy. Clin Pharmacol Ther. 1977 Sep;22(3):352–357. doi: 10.1002/cpt1977223352. [DOI] [PubMed] [Google Scholar]
  16. Nelson H. S., Raine D., Jr, Doner H. C., Posey W. C. Subsensitivity to the bronchodilator action of albuterol produced by chronic administration. Am Rev Respir Dis. 1977 Nov;116(5):871–878. doi: 10.1164/arrd.1977.116.5.871. [DOI] [PubMed] [Google Scholar]
  17. Rugg E. L., Barnett D. B., Nahorski S. R. Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies. Mol Pharmacol. 1978 Nov;14(6):996–1005. [PubMed] [Google Scholar]
  18. Svedmyr N. L., Larsson S. A., Thiringer G. K. Development of "resistance" in beta-adrenergic receptors of asthmatic patients. Chest. 1976 Apr;69(4):479–483. doi: 10.1378/chest.69.4.479. [DOI] [PubMed] [Google Scholar]
  19. Taplin G. V., Chopra S. K. Lung perfusion-inhalation scintigraphy in obstructive airway disease and pulmonary embolism. Radiol Clin North Am. 1978 Dec;16(3):491–513. [PubMed] [Google Scholar]
  20. Warrell D. A., Robertson D. G., Howes J. N., Conolly M. E., Paterson J. W., Beilin L. J., Dollery C. T. Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J. 1970 Jan 10;1(5688):65–70. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES